Bone marrow transplantation for the treatment of leukemia is increasingly successful in rendering patients disease free. However, it has become evident that the associated severe immunosuppression predisposes this population to an increased risk for other neoplastic disorders. We report on six patients in whom non-Hodgkin's lymphoma of the tonsillar region developed within 5 months after T-cell-depleted bone marrow transplantation for the treatment of leukemia at Memorial Sloan-Kettering Cancer Center from October 1990 to October 1992. These patients initially had what appeared to be infectious exudative pharyngitis/tonsillitis; however, they did not improve with medical therapy. Because of the persistence of pharyngitis/tonsillitis in association with cervical lymphadenopathy and odynophagia, the patients underwent definitive biopsy in the form of tonsillectomy, cervical lymph node biopsy, or both. Histopathologic review revealed non-Hodgkin's lymphoma. An association with Epstein-Barr virus has been noted in five of these patients. This article is aimed at alerting the clinician to consider the diagnosis of lymphoma in a patient with persistent pharyngitis/tonsillitis despite adequate medical therapy after bone marrow transplantation.
Get full access to this article
View all access options for this article.
References
1.
SocieGKolbHJLjungmanP.Malignant diseases after allogenic bone marrow transplantation: The case for assessment of risk factors. Br J Haematol1992; 80:427–30.
2.
ShapiroRSMcClainKFrizzeraGEpstein-Barr virus associated B-cell lymphoproliferative disorders following bone marrow transplantation. Blood1988; 71:1234–43.
3.
SwerdlowSHPost-transplant lymphoproliferative disorders: A morphologic phenotypic and genotypic spectrum of disease. Histopathology1992; 20:373–85.
4.
ZutterMMMartinPJSaleGEEpstein-Barr virus lymphoproliferation after bone marrow transplantation. Blood1988; 72:520–9.
5.
MartinPJShulmanHMSchubachWHFatal Epstein-Barr-virus-associated proliferation of donor B cells after treatment of acute graft-versus-host disease with a murine anti-T-cell antibody. Ann Intern Med1984; 101:310–5.
6.
ClearyMLNalesnickMAShearerWTSklarJ.Clonal analysis of transplant-associated lymphoproliferations based on the structure of the genomic termini of the Epstein-Barr virus. Blood1988; 72:349–52.
7.
FischerABlancheSLeBidoisJAnti-B-cell monoclonal antibodies in the treatment of severe B-cell lymphoproliferative syndrome following bone marrow and organ transplantation. N Engl J Med1991; 324:1451–6.
8.
PapadopoulosEBLadanyiMEmanuelDInfusion of donor leukocytes to treat EBV-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med1994; 330:1185–91.
9.
National Cancer Institute.Study of classification of non-Hodgkin's lymphoma: Summary and description of a working formulation for clinical usage. Cancer1982; 49:2112–35.
10.
Raab-TraubNFlynnK.The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell1986; 47:883–9.
11.
CathomasGMorrisPPekleKCunninghamIEmanuelD.Rapid diagnosis of cytomegalovirus pneumonia in marrow transplant recipients by bronchoalveolar lavage using the polymerase chain reaction, virus culture, and the direct immunostaining of alveolar cells. Blood1993; 81:1909–14.
12.
CheungAKieffE.Long direct repeat in Epstein-Barr vims DNA. J Virol1982; 44:286–94.
13.
AkaoISatoYMukaiKDetection of Epstein-Barr virus DNA in formalin-fixed paraffin-embedded tissue of nasopharyngeal carcinoma using polymerase chain reaction and in situ hybridization. Laryngoscope1991; 101:279–83.
14.
MackinnonSBarnettLBourhisJHMyeloid and lymphoid chimerism after T-cell depleted bone marrow transplantation: Evaluation of conditioning regimens using the polymerase chain reaction to amplify human minisatellite regions of genomic DNA. Blood1992; 80:3235–41.
15.
MarininchiDGluckmanEBlaiseDImpact of T-cell depletion on outcome of allogenic bone marrow transplantation for standard-risk leukemias. Lancet1987; 2:175–8.
16.
MitsuyasuRChamplinREGaleRPDepletion of T lymphocytes from donor bone marrow for the prevention of graft-versus-host disease following bone marrow transplantation. Ann Intern Med1986; 105:20–6.
17.
GlucksbergHStorbRFeferA.Clinical manifestations of graft-versus-host disease in human recipients of marrow from HLA-identical sibling donors. Transplantation1974; 18:295–304.
ChamplinR.T-cell depletion to prevent graft-versus-host disease after bone marrow transplantation. Hematol Oncol Clin North Am1990; 4:687–95.
20.
MarmontAMHorowitzMMGaleRPT-cell depletion of HLA-identical transplants in leukemia. Blood1991; 78:2120–30.
21.
NalesnickMAJaffeRStarzlTEThe pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol1993; 133:173–92.
22.
FrizzeraGHantoDWGajl-PeczalskaKJPolymorphic diffuse B-cell hyperplasias and lymphomas in renal transplant recipients. Cancer Res1981; 41:4262–79.
23.
KatzBZRaab-TraubNMillerG.Latent and replicating forms of Epstein-Barr virus DNA in lymphomas and lymphoproliferative diseases. J Infect Dis1989; 160:589–98.
24.
WitherspoonRPFischerLDSchochGSecondary cancers after bone marrow transplantation for leukemia or aplastic anemia. N Engl J Med1989; 321:784–9.
25.
PopeJHHomeMKScottW.Transformation of foetal human leukocytes in vitro by filtrates of human leukemic cell line containing herpes-like virus. Int J Cancer1968; 3:857–66.
26.
PopeJHEstablishment of cell lines from peripheral leukocytes in infectious mononucleosis. Nature1967; 216:810–1.
27.
RickinsonABCellular immunologic responses to the virus infection. In: EpsteinMAAchongBG, eds. The Epstein-Barr virus: recent advances. New York: Wiley and Sons, 1986:75.
28.
KleinEMassuciMGCell-mediated immunity against Epstein-Barr virus infected B lymphocytes. Springer Semin Immunopathol1982; 5:63–7.
29.
WallaceLERickinsonABRoweMEpstein-Barr virus specific cytotoxic T-cell clones restricted through a single HLA antigen. Nature1982; 297:413–5.
30.
CrawfordDHIliescuVEdwardsAJCharacterization of Epstein-Barr virus-specific memory T cells from the peripheral blood of seropositive individuals. Br J Cancer1983; 47:681–6.
31.
SixbeyJWNedrudJCRaab-TraubNEpstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med1984; 310:1225–30.
32.
StrauchBAndrewsLSiegelNOropharyngeal secretion of Epstein-Barr virus by renal transplant recipients and other patients treated with immunosuppressive drugs. Lancet1974; 1:234–7.
33.
CheesemanSHHenleWRubenRHEpstein-Barr virus infection in renal transplant recipients: Effects of anti-thymocyte globulin and interferon. Ann Intern Med1980; 93:39–42.
34.
DuncombeASGrundyJEOblakowskiPBone marrow transplant recipients have defective MHC-unrestricted cytotoxic responses against cytomegalovirus in comparison with Epstein-Barr virus: The importance of target cell expression of lymphocyte function-associated antigen 1 (LFA1). Blood1992; 79:3059–66.
